COVID vaccines are expected to be more costly and difficult to obtain for tens of millions of Americans this fall, says reports from Bloomberg and The New York Times.

With vaccine skeptic Robert F. Kennedy Jr. leading the Department of Health and Human Services, the Food and Drug Administration narrowed its approvals for COVID vaccines this week, which will reportedly force many to pay $225 for their next jab.

That’s because the FDA’s narrowing of approval—to only those aged 65 and older or those with qualifying conditions—will lead to the CDC following suit, meaning health plans that follow federal recommendations will no longer have to cover vaccine costs.

The result: Americans who want to protect themselves from COVID this fall, when infections from respiratory viruses typically inc

See Full Page